SideChannel, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SideChannel, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Sep 30, 2018 | $316.2K | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | $467.3K | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | $341.5K | Jan 12, 2018 |
| FY2014 | Sep 30, 2014 | $1.34M | Jan 5, 2015 |
| FY2014 | Sep 30, 2013 | $516.9K | Jan 5, 2015 |
| FY2014 | Sep 30, 2012 | $487.7K | Feb 5, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $7.35M | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | $7.40M | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | $6.57M | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | $4.79M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $2.80M | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | $48.0K | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | $46.6K | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | $316.2K | Jan 10, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.50M | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | $3.53M | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | $3.33M | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | $2.32M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $1.26M | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | $48.0K | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | $46.6K | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | $227.0K | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | $346.1K | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | $250.6K | Jan 12, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($892.0K) | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | ($904.0K) | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | ($7.01M) | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | ($11.78M) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $513.0K | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | ($6.97M) | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | ($6.83M) | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | ($4.42M) | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | ($4.42M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($2.64M) | Jan 12, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($918.0K) | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | ($940.0K) | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | ($7.41M) | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | ($11.59M) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $510.0K | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | ($6.93M) | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | ($6.84M) | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | ($3.12M) | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | ($4.37M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($2.65M) | Jan 12, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $562.0K | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | $546.0K | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | $669.0K | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | $178.0K | Dec 27, 2023 |
| FY2021 | Sep 30, 2021 | $616.7K | Dec 21, 2021 |
| FY2021 | Sep 30, 2020 | $1.69M | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | $1.74M | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | $873.1K | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | $1.09M | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | $755.2K | Jan 12, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($130.0K) | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | $307.0K | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | ($1.95M) | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | ($396.0K) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $157.0K | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | ($6.65M) | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | ($6.14M) | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | ($2.30M) | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | ($1.79M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($2.57M) | Jan 12, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2024 | $15.0K | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | $32.0K | Dec 13, 2024 |
| FY2021 | Sep 30, 2020 | $29.0K | Dec 21, 2021 |
| FY2016 | Sep 30, 2016 | $16.0K | Feb 2, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.47M | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | $3.95M | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | $3.98M | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | $10.77M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $833.0K | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | $1.83M | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | $8.01M | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | $14.09M | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | $250.8K | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | $417.5K | Jan 12, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.32M | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | $1.25M | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | $954.0K | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | $1.37M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $406.0K | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | $1.97M | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | $821.4K | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | $124.5K | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | $907.7K | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | $1.27M | Jan 12, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.14M | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | $2.70M | Dec 18, 2025 |
| FY2025 | Sep 30, 2023 | $3.03M | Dec 18, 2025 |
| FY2024 | Sep 30, 2022 | $9.40M | Dec 13, 2024 |
| FY2023 | Sep 30, 2021 | $427.0K | Dec 27, 2023 |
| FY2022 | Sep 30, 2020 | $214.0K | Dec 20, 2022 |
| FY2021 | Sep 30, 2019 | $7.19M | Dec 21, 2021 |
| FY2020 | Sep 30, 2018 | $13.96M | Dec 29, 2020 |
| FY2019 | Sep 30, 2017 | ($656.9K) | Jan 10, 2020 |
| FY2018 | Sep 30, 2016 | ($848.6K) | Dec 31, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.36M | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | $1.36M | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | $1.36M | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | $1.36M | Dec 27, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($20.74M) | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | ($19.84M) | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | ($18.94M) | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | ($11.93M) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $344.0K | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | ($68.43M) | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | ($61.46M) | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | ($54.62M) | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | ($50.20M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($45.78M) | Jan 12, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2024 | $6.0K | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | $42.0K | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | $3.03M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $348.0K | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | $1.08M | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | $7.84M | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | $14.06M | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | $227.4K | Dec 31, 2018 |
| FY2018 | Sep 30, 2016 | $344.1K | Dec 31, 2018 |
| FY2017 | Sep 30, 2015 | $1.99M | Jan 12, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Sep 30, 2020 | $365.4K | Dec 29, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Dec 20, 2022 |
| FY2011 | Sep 30, 2011 | 0 | Oct 10, 2013 |
| FY2011 | Sep 30, 2010 | 0 | Oct 10, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Dec 27, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 231.23M | Dec 18, 2025 |
| FY2025 | Sep 30, 2024 | 225.98M | Dec 18, 2025 |
| FY2024 | Sep 30, 2023 | 213.85M | Dec 13, 2024 |
| FY2023 | Sep 30, 2022 | 148.72M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | 59.90M | Dec 20, 2022 |
| FY2021 | Sep 30, 2020 | 27.51M | Dec 21, 2021 |
| FY2020 | Sep 30, 2019 | 40.79M | Dec 29, 2020 |
| FY2019 | Sep 30, 2018 | 40.74M | Jan 10, 2020 |
| FY2018 | Sep 30, 2017 | 6.64M | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | 5.27M | Jan 12, 2018 |